Calidi Biotherapeutics (NYSE American: CLDI) presented data at the International Oncolytic Virotherapy Conference and the Society for Immunotherapy of Cancer Annual Meeting highlighting its RTNova ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback